This study is testing a new weekly injection called CT-388 to see if it can help people who are overweight or obese and have type 2 diabetes. About 360 participants will receive either the drug or a placebo (dummy shot) for 48 weeks. The main goals are to see how much weight peop…
Phase: PHASE2 • Sponsor: Carmot Therapeutics, Inc. • Aim: Disease control
Last updated Feb 25, 2026 15:08 UTC